European court rules Teva, Cephalon must pay $60M fine for reverse payment scheme after failed appeal
Teva and its subsidiary Cephalon’s hopes that a European court would dismiss or reduce more than $60 million in fines have been dashed after …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
